MPIA
BMY icon

Mountain Pacific Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Mountain Pacific Investment Advisers’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,712
Closed -$209K – 130
2022
Q2 		$209K Buy
+2,712
New +$207K 0.02% 128
2018
Q4 		– Sell
-1,012
Closed -$63K – 125
2018
Q3 		$63K Buy
+1,012
New +$60.1K 0.01% 171

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mountain Pacific Investment Advisers's BMY Position: Q3 2022 in Review

Mountain Pacific Investment Advisers sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 2,712 shares — an estimated $209K sold.

Mountain Pacific Investment Advisers first reported a position in BMY in Q3 2018 and held it in 2 quarters. The position peaked at $209K in Q2 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Mountain Pacific Investment Advisers reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Mountain Pacific Investment Advisers sold 2,712 Bristol-Myers Squibb shares in Q3 2022, an estimated $209K.
  • Mountain Pacific Investment Advisers first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 2 quarters.
  • Mountain Pacific Investment Advisers's Bristol-Myers Squibb position peaked at $209K in Q2 2022.
  • 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Mountain Pacific Investment Advisers's 13F filing for Q3 2022, filed 13 Oct 2022.